Study In Urology Practices Looking At Impact Of OncotypeDX GPS Test On Men Choosing And Remaining On Active Surveillance
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2018-04-18
- Last Posted Date
- 2021-04-23
- Lead Sponsor
- Genomic Health®, Inc.
- Target Recruit Count
- 489
- Registration Number
- NCT03502213
Evaluation of a Blood Biomarker to Try and Distinguish Between the Presence or Absence of Aggressive Prostate Cancer
Terminated
- Conditions
- Prostate Cancer
- First Posted Date
- 2017-08-22
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Genomic Health®, Inc.
- Target Recruit Count
- 128
- Registration Number
- NCT03256630
- Locations
- 🇺🇸
Florida Hospital Global Robotics Institute, Celebration, Florida, United States
Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer
Completed
- Conditions
- Non-muscle Invasive Bladder Cancer
- First Posted Date
- 2016-11-21
- Last Posted Date
- 2021-03-02
- Lead Sponsor
- Genomic Health®, Inc.
- Target Recruit Count
- 417
- Registration Number
- NCT02969109
- Locations
- 🇺🇸
Institute for Prostate and Urologic Cancers - University of Minnesota, Minneapolis, Minnesota, United States
Concordance of Key Actionable Genomic Alterations as Assessed in Tumor Tissue and Plasma in Non Small Cell Lung Cancer
Terminated
- Conditions
- Non Small Cell Lung Carcinoma
- First Posted Date
- 2016-05-05
- Last Posted Date
- 2020-11-17
- Lead Sponsor
- Genomic Health®, Inc.
- Target Recruit Count
- 140
- Registration Number
- NCT02762877
- Locations
- 🇺🇸
Cancer Care Associates d/b/a Torrance Memorial Physician Network, Torrance, California, United States
🇺🇸Central Georgia Cancer Care, Macon, Georgia, United States
🇺🇸Bon Secours Cancer Institute, Midlothian, Virginia, United States
Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer Patients
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- Device: Oncotype DX breast cancer test
- First Posted Date
- 2011-10-05
- Last Posted Date
- 2013-04-18
- Lead Sponsor
- Genomic Health®, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT01446185
- Locations
- 🇫🇷
Centre Jean Perrin, Clermont-Ferrand, France
🇫🇷Centre d'Oncologie Médicale de Gentilly, Nancy, France
🇫🇷Centre Val d'Aurelle, Montpellier, France
© Copyright 2025. All Rights Reserved by MedPath